(Q35065022)

English

Association of peroxisome proliferator-activated receptor γ Pro12Ala gene polymorphism with type 2 diabetic nephropathy risk in Caucasian population

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

0 references

Association of peroxisome proliferator-activated receptor γ Pro12Ala gene polymorphism with type 2 diabetic nephropathy risk in Caucasian population (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

diabetic nephropathy

1 reference

based on heuristic

inferred from title

author name string

Tian-Biao Zhou

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Xue-Feng Guo

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sheng-Sheng Yin

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

16 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Journal of Receptors and Signal Transduction

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

180-184

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PTB-associated splicing factor (PSF) is a PPARγ-binding protein and growth regulator of colon cancer cells

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.868905

21 January 2018

Signaling Crosstalk between PPARγ and BMP2 in Mesenchymal Stem Cells

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.868905

21 January 2018

Peroxisome proliferator-activated receptor-γ agonist pioglitazone suppresses experimental autoimmune uveitis

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.868905

21 January 2018

Is the Hp 2-2 diabetic mouse model a good model to study diabetic nephropathy?

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.868905

21 January 2018

Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study.

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.868905

21 January 2018

Association of matrix metalloproteinase-9 level with the risk of renal involvement for Henoch-Schönlein purpura in children

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.868905

21 January 2018

A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients.

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.868905

21 January 2018

Relationship between GSTM1/GSTT1 null genotypes and renal cell carcinoma risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.868905

21 January 2018

Association of apoE gene expression and its gene polymorphism with nephrotic syndrome susceptibility: a meta-analysis of experimental and human studies

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.868905

21 January 2018

Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism with the risk of end-stage renal disease

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.868905

21 January 2018

Association of angiotensin II type-1 receptor A1166C gene polymorphism with the susceptibility of end-stage renal disease

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.868905

21 January 2018

Operating characteristics of a rank correlation test for publication bias

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.868905

21 January 2018

The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.868905

21 January 2018

Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.868905

21 January 2018

Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.868905

21 January 2018

The association between the PPARγ2 Pro12Ala polymorphism and nephropathy susceptibility in type 2 diabetes: a meta-analysis based on 9,176 subjects

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.868905

21 January 2018

Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.868905

21 January 2018

PPAR 2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies

1 reference

https://api.crossref.org/works/10.3109%2F10799893.2013.868905

21 January 2018

Identifiers

10.3109/10799893.2013.868905

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35065022&oldid=1945253897"